DJIA 17,976.31 263.65 1.49%
NASDAQ 4,947.44 0.00 0.00%
S&P 500 2,086.24 25.22 1.22%
market minute promo

Abbott Laboratories (NYSE: ABT)

47.08 0.30 (0.64%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ABT $47.08 0.64%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.00
Previous Close $46.78
Daily Range $46.89 - $47.21
52-Week Range $36.65 - $47.88
Market Cap $71.0B
P/E Ratio 41.77
Dividend (Yield) $0.96 (2.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,967,105
Average Daily Volume 5,380,066
Current FY EPS $2.15




Drug Makers

Abbott Laboratories (ABT) Description

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Website:

News & Commentary Rss Feed

The Single Worst Practice of the Drug Industry

Pay for delay is a legal maneuver Big Pharma uses to keep generic drugs off the market. According to the FTC, it costs consumers and taxpayers $3.5 billion every year.

Today's Market: Healthcare, Technology Mergers And Acquisitions Boosting These Stocks

The Best Stocks To Buy This Week

Dividend Achievers Top 20 Hits The Mark, Again

The Philosopher Series, Part XV: What Would Bacon Invest In Today?

Mylan Is One Of The Most Undervalued Generic Companies

Sucampo Pharmaceuticals Revamp Impresses Wall Street

The Best Stocks To Buy This Week

Abbott Laboratories: Dividend Stock Analysis

Insider Trading Alert - SF, SJI And ABT Traded By Insiders

See More ABT News...

ABT's Top Competitors

ABT $47.08 (0.64%)
Current stock: ABT
JNJ $101.55 (1.21%)
Current stock: JNJ
NVS $101.31 (0.91%)
Current stock: NVS
RHHBY $34.21 (-0.12%)
Current stock: RHHBY